MedWatch

Analysts have great faith in incoming Ambu CEO

Britt Meelby Jensen, who was appointed the new chief executive of Ambu yesterday, is the obvious candidate to rebuild trust in the medtech firm after years of downgrades, say analysts.

Photo: PR / Ambu

Britt Meelby Jensen, who was appointed the next CEO of Ambu on Thursday, is the right person for the job of reestablishing faith in the medtech company, which has disappointed analysts with seven downgrades since 2019, say a number of analysts according to Danish media Finans.

”Britt Meelby Jensen is the obvious candidate. She has gained a lot of credit from the market, in part due to her role at Atos Medical. Now, she’s facing a turnaround, and I can’t quite conclude that she’s done that before. That’s not to say she won’t be up for the task, and it is my impression that she’s sharp and a hard worker,” one analyst, Jesper Ingildsen of DNB Markets London, says to the media.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs